XML 89 R78.htm IDEA: XBRL DOCUMENT v3.23.3
SEGMENT INFORMATION - Summary of Reportable Segments (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Jan. 01, 2023
segment
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
segment
Sep. 30, 2022
USD ($)
Segment Reporting [Abstract]          
Number of reportable segments | segment       3  
Number of operating segments realigned | segment 2        
Financial information regarding the Company's reportable segments          
Net Sales   $ 892,997 $ 836,860 $ 2,648,970 $ 2,526,335
Acquisition related costs   0 (231) (255) (231)
Restructuring initiatives   (6,161) (2,270) (19,628) (2,989)
Net unrealized investment (loss) gain   (5,428) 277 (2,349) (2,297)
Depreciation and amortization   (62,686) (57,601) (184,212) (174,818)
Interest expense   (9,984) (9,756) (29,900) (30,668)
Interest income   946 752 2,266 2,029
Income before Income Taxes   110,049 84,915 294,196 261,012
Optimization Initiative          
Financial information regarding the Company's reportable segments          
Restructuring initiatives   (6,586) (2,254) (20,069) (2,254)
Prior Year Initiatives          
Financial information regarding the Company's reportable segments          
Restructuring initiatives   425 (16) 441 (735)
Aptar Pharma          
Financial information regarding the Company's reportable segments          
Net Sales   389,188 343,397 1,135,934 1,026,090
Aptar Beauty          
Financial information regarding the Company's reportable segments          
Net Sales   323,980 303,046 979,956 929,793
Aptar Closures          
Financial information regarding the Company's reportable segments          
Net Sales   179,829 190,417 533,080 570,452
Operating segment          
Financial information regarding the Company's reportable segments          
Net Sales   901,452 846,138 2,678,225 2,562,575
Operating segment | Aptar Pharma          
Financial information regarding the Company's reportable segments          
Net Sales   389,423 345,079 1,136,544 1,037,120
Adjusted EBITDA   136,344 107,235 371,508 333,793
Restructuring initiatives   (92) 0 (1,657) 0
Operating segment | Aptar Beauty          
Financial information regarding the Company's reportable segments          
Net Sales   330,467 308,353 1,002,209 947,515
Adjusted EBITDA   41,070 36,563 121,375 112,343
Restructuring initiatives   (2,880) (2,240) (12,650) (2,774)
Operating segment | Aptar Closures          
Financial information regarding the Company's reportable segments          
Net Sales   181,562 192,706 539,472 577,940
Adjusted EBITDA   27,607 23,483 81,387 69,020
Restructuring initiatives   (3,098) (30) (4,060) (215)
Intersegment          
Financial information regarding the Company's reportable segments          
Net Sales   8,455 9,278 29,255 36,240
Intersegment | Aptar Pharma          
Financial information regarding the Company's reportable segments          
Net Sales   235 1,682 610 11,030
Intersegment | Aptar Beauty          
Financial information regarding the Company's reportable segments          
Net Sales   6,487 5,307 22,253 17,722
Intersegment | Aptar Closures          
Financial information regarding the Company's reportable segments          
Net Sales   1,733 2,289 6,392 7,488
Corporate & Other, unallocated          
Financial information regarding the Company's reportable segments          
Adjusted EBITDA   (11,659) (13,537) (45,996) (45,170)
Restructuring initiatives   $ (91) $ 0 $ (1,261) $ 0